154 related articles for article (PubMed ID: 12693954)
21. Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis.
D'Armiento J; Imai K; Schiltz J; Kolesnekova N; Sternberg D; Benson K; Pardo A; Selman M; Smolarek T; Vundavalli M; Sonnet J; Szabolcs M; Chada K
Cancer Res; 2007 Mar; 67(5):1902-9. PubMed ID: 17332316
[TBL] [Abstract][Full Text] [Related]
22. Expression of HMGA2-LPP and LPP-HMGA2 fusion genes in lipoma: identification of a novel type of LPP-HMGA2 transcript in four cases.
Kubo T; Matsui Y; Naka N; Araki N; Goto T; Yukata K; Endo K; Yasui N; Myoui A; Kawabata H; Yoshikawa H; Ueda T
Anticancer Res; 2009 Jun; 29(6):2357-60. PubMed ID: 19528502
[TBL] [Abstract][Full Text] [Related]
23. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes.
Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R
Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370
[TBL] [Abstract][Full Text] [Related]
24. Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas.
Mine N; Kurose K; Nagai H; Doi D; Ota Y; Yoneyama K; Konishi H; Araki T; Emi M
J Hum Genet; 2001; 46(7):408-12. PubMed ID: 11450849
[TBL] [Abstract][Full Text] [Related]
25. Specific recognition of AT-rich DNA sequences by the mammalian high mobility group protein AT-hook 2: a SELEX study.
Cui T; Leng F
Biochemistry; 2007 Nov; 46(45):13059-66. PubMed ID: 17956125
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
27. DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells.
Li O; Li J; Dröge P
FEBS Lett; 2007 Jul; 581(18):3533-7. PubMed ID: 17624332
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of HMGA2-LPP fusion transcripts promotes expression of the alpha 2 type XI collagen gene.
Kubo T; Matsui Y; Goto T; Yukata K; Yasui N
Biochem Biophys Res Commun; 2006 Feb; 340(2):476-81. PubMed ID: 16375854
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of a free kappaB DNA: insights into DNA recognition by transcription factor NF-kappaB.
Huang DB; Phelps CB; Fusco AJ; Ghosh G
J Mol Biol; 2005 Feb; 346(1):147-60. PubMed ID: 15663934
[TBL] [Abstract][Full Text] [Related]
30. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.
Thuault S; Valcourt U; Petersen M; Manfioletti G; Heldin CH; Moustakas A
J Cell Biol; 2006 Jul; 174(2):175-83. PubMed ID: 16831886
[TBL] [Abstract][Full Text] [Related]
32. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
34. Synergistic activation of the CMV promoter by NF-kappaB P50 and PKG.
He B; Weber GF
Biochem Biophys Res Commun; 2004 Aug; 321(1):13-20. PubMed ID: 15358208
[TBL] [Abstract][Full Text] [Related]
35. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas.
Dahlén A; Mertens F; Rydholm A; Brosjö O; Wejde J; Mandahl N; Panagopoulos I
Mod Pathol; 2003 Nov; 16(11):1132-40. PubMed ID: 14614053
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells.
Ishikawa F; Nose K; Shibanuma M
Exp Cell Res; 2008 Jun; 314(10):2131-40. PubMed ID: 18433744
[TBL] [Abstract][Full Text] [Related]
37. Oxidized guanine lesions as modulators of gene transcription. Altered p50 binding affinity and repair shielding by 7,8-dihydro-8-oxo-2'-deoxyguanosine lesions in the NF-kappaB promoter element.
Hailer-Morrison MK; Kotler JM; Martin BD; Sugden KD
Biochemistry; 2003 Aug; 42(32):9761-70. PubMed ID: 12911319
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma.
Ingraham SE; Lynch RA; Surti U; Rutter JL; Buckler AJ; Khan SA; Menon AG; Lepont P
Mutat Res; 2006 Dec; 602(1-2):43-53. PubMed ID: 17045619
[TBL] [Abstract][Full Text] [Related]
39. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
40. A functional NF-kappaB enhancer element in the first intron contributes to the control of c-fos transcription.
Charital YM; van Haasteren G; Massiha A; Schlegel W; Fujita T
Gene; 2009 Feb; 430(1-2):116-22. PubMed ID: 19026727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
